This document proposes a model using blockchain and machine learning for supply chain management and demand forecasting of COVID-19 vaccines. The objectives are to determine vaccine distribution by location and time, and ensure transparency. Challenges include integrating the technologies, data privacy, and getting competitors to share data. The proposed model focuses on geographical forecasting and not vaccine efficacy. Future work includes implementing the model and comparing machine learning algorithms for forecasting.
The FAIR (Findable, Accessible, Interoperable, Reusable) Guiding Principles light a path towards improving the discovery and reuse of digital objects (data, documents, software, web services, etc) by machines. Machine reusability is a crucial strategic component in building robust digital infrastructure that strengthens scholarship and opens new pathways for innovation on a truly global scale. However, as the FAIR principles do not specify any particular implementation, communities have the homework to devise, standardize and implement technical specifications to improve the ‘FAIRness’ of digital assets. In this seminar, I will focus on the history and state of the art in the FAIRness assessment, including manual, semi-automated and fully automated approaches, and how these can be used by developers and consumers alike. This seminar will serve as a springboard for community discussion and adoption of these services to incrementally and realistically improve the FAIRness of their resources.
Acclerating biomedical discovery with an internet of FAIR data and services -...Michel Dumontier
With its focus on improving the health and well being of people, biomedicine has always been a fertile, if not challenging domain for computational discovery science. Indeed, the existence of millions of scientific articles, thousands of databases, and hundreds of ontologies, offer exciting opportunities to reuse our collective knowledge, were we not stymied by incompatible formats, overlapping and incomplete vocabularies, unclear licensing, and heterogeneous access points. In this talk, I will discuss our work to create computational standards, platforms, and methods to wrangle knowledge into simple, but effective representations based on semantic web technologies that are maximally FAIR - Findable, Accessible, Interoperable, and Reuseable - and to further use these for biomedical knowledge discovery. But only with additional crucial developments will this emerging Internet of FAIR data and services, which is built on Semantic Web technologies, be well positioned to support automated scientific discovery on a global scale.
PharmaLedger Press Release #2 June 2020 PharmaLedger
PharmaLedgers June 2020 press release covers the strong foundations in the project’s first year and how it set the stage for accelerated development and ecosystem engagement.
The press release also announces the establishment of PharmaLedger’s Advisory Board and the outlook for 2021.
—
This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 853992. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.
Disclaimer: Any information on this presentation solely reflects the author’s view and neither IMI nor the European Union or EFPIA are responsible for any use that may be made of the information contained herein.
CIKM2020 Keynote: Accelerating discovery science with an Internet of FAIR dat...Michel Dumontier
Biomedicine has always been a fertile and challenging domain for computational discovery science. Indeed, the existence of millions of scientific articles, thousands of databases, and hundreds of ontologies, offer exciting opportunities to reuse our collective knowledge, were we not stymied by incompatible formats, overlapping and incomplete vocabularies, unclear licensing, and heterogeneous access points. In this talk, I will discuss our work to create computational standards, platforms, and methods to wrangle knowledge into simple, but effective representations based on semantic web technologies that are maximally FAIR - Findable, Accessible, Interoperable, and Reuseable - and to further use these for biomedical knowledge discovery. But only with additional crucial developments will this emerging Internet of FAIR data and services enable automated scientific discovery on a global scale.
bio:
Dr. Michel Dumontier is the Distinguished Professor of Data Science at Maastricht University and co-founder of the FAIR (Findable, Accessible, Interoperable and Reusable) data principles. His research focuses on the development of computational methods for scalable and responsible discovery science. Dr. Dumontier obtained his BSc (Biochemistry) in 1998 from the University of Manitoba, and his PhD (Bioinformatics) in 2005 from the University of Toronto. Previously a faculty member at Carleton University in Ottawa and Stanford University in Palo Alto, Dr. Dumontier founded and directs the interfaculty Institute of Data Science at Maastricht University to develop sociotechnological systems for responsible data science by design. His work is supported through the Dutch National Research Agenda, the Netherlands Organisation for Scientific Research, Horizon 2020, the European Open Science Cloud, the US National Institutes of Health and a Marie-Curie Innovative Training Network. He is the editor-in-chief for the journal Data Science and is internationally recognized for his contributions in bioinformatics, biomedical informatics, and semantic technologies including ontologies and linked data.
This presentation was given on October 21, 2020 at CIKM2020.
Ethical documentation, data and site managementZeta Research
Managing the process of ethical submission and approval of the study, development of data collection tools, data management, monitoring ,for a premarket Pediatric Medical Device (class II) trial.
BigInsight seminar on Practical Privacy-Preserving Distributed Statistical Co...Statistisk sentralbyrå
Seminar Monday March 5th 2018 by BigInsight and Statistics Norway: Presentation by Kassaye Yitbarek Yigzaw. Distributed data analysis in the face og privacy concerns.
The FAIR (Findable, Accessible, Interoperable, Reusable) Guiding Principles light a path towards improving the discovery and reuse of digital objects (data, documents, software, web services, etc) by machines. Machine reusability is a crucial strategic component in building robust digital infrastructure that strengthens scholarship and opens new pathways for innovation on a truly global scale. However, as the FAIR principles do not specify any particular implementation, communities have the homework to devise, standardize and implement technical specifications to improve the ‘FAIRness’ of digital assets. In this seminar, I will focus on the history and state of the art in the FAIRness assessment, including manual, semi-automated and fully automated approaches, and how these can be used by developers and consumers alike. This seminar will serve as a springboard for community discussion and adoption of these services to incrementally and realistically improve the FAIRness of their resources.
Acclerating biomedical discovery with an internet of FAIR data and services -...Michel Dumontier
With its focus on improving the health and well being of people, biomedicine has always been a fertile, if not challenging domain for computational discovery science. Indeed, the existence of millions of scientific articles, thousands of databases, and hundreds of ontologies, offer exciting opportunities to reuse our collective knowledge, were we not stymied by incompatible formats, overlapping and incomplete vocabularies, unclear licensing, and heterogeneous access points. In this talk, I will discuss our work to create computational standards, platforms, and methods to wrangle knowledge into simple, but effective representations based on semantic web technologies that are maximally FAIR - Findable, Accessible, Interoperable, and Reuseable - and to further use these for biomedical knowledge discovery. But only with additional crucial developments will this emerging Internet of FAIR data and services, which is built on Semantic Web technologies, be well positioned to support automated scientific discovery on a global scale.
PharmaLedger Press Release #2 June 2020 PharmaLedger
PharmaLedgers June 2020 press release covers the strong foundations in the project’s first year and how it set the stage for accelerated development and ecosystem engagement.
The press release also announces the establishment of PharmaLedger’s Advisory Board and the outlook for 2021.
—
This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 853992. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.
Disclaimer: Any information on this presentation solely reflects the author’s view and neither IMI nor the European Union or EFPIA are responsible for any use that may be made of the information contained herein.
CIKM2020 Keynote: Accelerating discovery science with an Internet of FAIR dat...Michel Dumontier
Biomedicine has always been a fertile and challenging domain for computational discovery science. Indeed, the existence of millions of scientific articles, thousands of databases, and hundreds of ontologies, offer exciting opportunities to reuse our collective knowledge, were we not stymied by incompatible formats, overlapping and incomplete vocabularies, unclear licensing, and heterogeneous access points. In this talk, I will discuss our work to create computational standards, platforms, and methods to wrangle knowledge into simple, but effective representations based on semantic web technologies that are maximally FAIR - Findable, Accessible, Interoperable, and Reuseable - and to further use these for biomedical knowledge discovery. But only with additional crucial developments will this emerging Internet of FAIR data and services enable automated scientific discovery on a global scale.
bio:
Dr. Michel Dumontier is the Distinguished Professor of Data Science at Maastricht University and co-founder of the FAIR (Findable, Accessible, Interoperable and Reusable) data principles. His research focuses on the development of computational methods for scalable and responsible discovery science. Dr. Dumontier obtained his BSc (Biochemistry) in 1998 from the University of Manitoba, and his PhD (Bioinformatics) in 2005 from the University of Toronto. Previously a faculty member at Carleton University in Ottawa and Stanford University in Palo Alto, Dr. Dumontier founded and directs the interfaculty Institute of Data Science at Maastricht University to develop sociotechnological systems for responsible data science by design. His work is supported through the Dutch National Research Agenda, the Netherlands Organisation for Scientific Research, Horizon 2020, the European Open Science Cloud, the US National Institutes of Health and a Marie-Curie Innovative Training Network. He is the editor-in-chief for the journal Data Science and is internationally recognized for his contributions in bioinformatics, biomedical informatics, and semantic technologies including ontologies and linked data.
This presentation was given on October 21, 2020 at CIKM2020.
Ethical documentation, data and site managementZeta Research
Managing the process of ethical submission and approval of the study, development of data collection tools, data management, monitoring ,for a premarket Pediatric Medical Device (class II) trial.
BigInsight seminar on Practical Privacy-Preserving Distributed Statistical Co...Statistisk sentralbyrå
Seminar Monday March 5th 2018 by BigInsight and Statistics Norway: Presentation by Kassaye Yitbarek Yigzaw. Distributed data analysis in the face og privacy concerns.
A talk prepared for Workshop Working on data stewardship? Meet your peers!
Datum: 03 OKT 2017
https://www.surf.nl/agenda/2017/10/workshop-working-on-data-stewardship-meet-your-peers/index.html
Monitor and Engage Clinical Trial Participants for better outcomeQuahog Life Sciences
Quahog platform provides a comprehensive solution for Clinical Trial administrators to collect and integrate data from devices, so that participant health parameters can be monitored daily and get rich insights on trial effectiveness. Monitoring in real-time can also allow them to handle adverse events more effectively
Joint Pistoia Alliance & PRISME AI in pharma webinar 18 Oct 2018Pistoia Alliance
In order to advance Machine Learning driven analytic approaches, having access to more data is better. In order to achieve increasingly larger patient level datasets, Researchers require the pooling of data from participants across the Healthcare ecosystem.
Common requirements and technical design patterns have emerged from company-specific and industry consortia efforts, forming underlying patterns that make up an overall Reference Architecture for data that can ultimately feed new analytics and Machine Learning.
Bridging Health Care and Clinical Trial Data through TechnologySaama
Karim Damji, SVP of Product and Marketing, presented at the Bridging Clinical Research and Clinical Health Care conference held at the Gaylord in National Harbor on April 4-5, 2018.
Building a Next Generation Clinical and Scientific Data Management SolutionSaama
Srini Anandakumar, Senior Director of Clinical Analytics Innovations for Saama Technologies, discussions next-generation data management solutions at the Drug Development Networking Summit on April 11, 2019, in Bridgewater, New Jersey.
Quahog Life Sciences is building an AI based Healthcare Decision System (Health DS) that promises to take the accuracy of health care decisions to a new level using machine learning and advanced analytics.
Information technology helps healthcare organizations in providing better services to patients and making better decisions. Some of the technologies like e-prescriptions, electronic transactions, and electronic medical records help in increasing the business functionality, removes data ambiguities, reduces the time of staff and physicians and enhances the relationship between the organization and patients. IT provides the ability to measure and monitor patients’ health and provides better analytics to physicians.
Integrated Healthcare Approach to manage multi-morbiditiesPeter Rosengren
The PICASO project will improve cooperation and exchange of knowledge between professional caregivers in health, rehabilitation and social care domains and actively include patients and their relatives in the integrated care settings thus supporting patient empowerment and self-care (the safe hand-off).
The project implements blockchain technology to support distributed electronic patient records and cloud service orchestration to support an holistic and integrated care approach
Cloud-Based Solutions for Clinical Data ManagementClinosolIndia
Cloud-based solutions have become increasingly popular in the field of clinical data management due to their scalability, accessibility, cost-effectiveness, and potential for collaboration. These solutions offer a range of benefits for managing and analyzing clinical data while ensuring security and compliance with regulatory requirements such as HIPAA. Here are some key cloud-based solutions for clinical data management
Risk Based Monitoring in Clinical trials_Aishwarya Janjale.pptxClinosolIndia
Risk-Based Monitoring (RBM) in clinical trials represents a departure from traditional, one-size-fits-all monitoring approaches. This innovative strategy tailors monitoring activities to the specific risks associated with a trial, optimizing resource utilization and enhancing data quality. This article explores the key principles, benefits, and challenges of RBM, illustrating its transformative impact on the landscape of clinical trial oversight.
Key Principles:
Risk Identification and Assessment:
RBM begins with a comprehensive assessment of potential risks to data integrity, patient safety, and study endpoints. These risks are identified based on factors such as study complexity, patient population, and investigational product characteristics.
The International Journal of Pharmacetical Sciences Letters (IJPSL) is an international online journal in English published everyday. The aim of this is to publish peer reviewed research and review articles without delay in the developing field of engineering and science Research.
A talk prepared for Workshop Working on data stewardship? Meet your peers!
Datum: 03 OKT 2017
https://www.surf.nl/agenda/2017/10/workshop-working-on-data-stewardship-meet-your-peers/index.html
Monitor and Engage Clinical Trial Participants for better outcomeQuahog Life Sciences
Quahog platform provides a comprehensive solution for Clinical Trial administrators to collect and integrate data from devices, so that participant health parameters can be monitored daily and get rich insights on trial effectiveness. Monitoring in real-time can also allow them to handle adverse events more effectively
Joint Pistoia Alliance & PRISME AI in pharma webinar 18 Oct 2018Pistoia Alliance
In order to advance Machine Learning driven analytic approaches, having access to more data is better. In order to achieve increasingly larger patient level datasets, Researchers require the pooling of data from participants across the Healthcare ecosystem.
Common requirements and technical design patterns have emerged from company-specific and industry consortia efforts, forming underlying patterns that make up an overall Reference Architecture for data that can ultimately feed new analytics and Machine Learning.
Bridging Health Care and Clinical Trial Data through TechnologySaama
Karim Damji, SVP of Product and Marketing, presented at the Bridging Clinical Research and Clinical Health Care conference held at the Gaylord in National Harbor on April 4-5, 2018.
Building a Next Generation Clinical and Scientific Data Management SolutionSaama
Srini Anandakumar, Senior Director of Clinical Analytics Innovations for Saama Technologies, discussions next-generation data management solutions at the Drug Development Networking Summit on April 11, 2019, in Bridgewater, New Jersey.
Quahog Life Sciences is building an AI based Healthcare Decision System (Health DS) that promises to take the accuracy of health care decisions to a new level using machine learning and advanced analytics.
Information technology helps healthcare organizations in providing better services to patients and making better decisions. Some of the technologies like e-prescriptions, electronic transactions, and electronic medical records help in increasing the business functionality, removes data ambiguities, reduces the time of staff and physicians and enhances the relationship between the organization and patients. IT provides the ability to measure and monitor patients’ health and provides better analytics to physicians.
Integrated Healthcare Approach to manage multi-morbiditiesPeter Rosengren
The PICASO project will improve cooperation and exchange of knowledge between professional caregivers in health, rehabilitation and social care domains and actively include patients and their relatives in the integrated care settings thus supporting patient empowerment and self-care (the safe hand-off).
The project implements blockchain technology to support distributed electronic patient records and cloud service orchestration to support an holistic and integrated care approach
Cloud-Based Solutions for Clinical Data ManagementClinosolIndia
Cloud-based solutions have become increasingly popular in the field of clinical data management due to their scalability, accessibility, cost-effectiveness, and potential for collaboration. These solutions offer a range of benefits for managing and analyzing clinical data while ensuring security and compliance with regulatory requirements such as HIPAA. Here are some key cloud-based solutions for clinical data management
Risk Based Monitoring in Clinical trials_Aishwarya Janjale.pptxClinosolIndia
Risk-Based Monitoring (RBM) in clinical trials represents a departure from traditional, one-size-fits-all monitoring approaches. This innovative strategy tailors monitoring activities to the specific risks associated with a trial, optimizing resource utilization and enhancing data quality. This article explores the key principles, benefits, and challenges of RBM, illustrating its transformative impact on the landscape of clinical trial oversight.
Key Principles:
Risk Identification and Assessment:
RBM begins with a comprehensive assessment of potential risks to data integrity, patient safety, and study endpoints. These risks are identified based on factors such as study complexity, patient population, and investigational product characteristics.
The International Journal of Pharmacetical Sciences Letters (IJPSL) is an international online journal in English published everyday. The aim of this is to publish peer reviewed research and review articles without delay in the developing field of engineering and science Research.
"Does blockchain hold the key to a new age of supply chain transparency and t...eraser Juan José Calderón
The report, "Does blockchain hold the key to a new age of supply chain transparency and trust?", provides a comprehensive overview into the businesses and geographies that are ramping up their blockchain readiness, and predicts that blockchain will enter mainstream use in supply chains by 2025. Currently, just 3% of organizations that are deploying blockchain do so at scale and 10% have a pilot in place, with 87% of respondents reporting to be in the early stages of experimentation with blockchain.
The UK (22%) and France (17%) currently lead the way with at-scale and pilot implementation1 of blockchain in Europe, while the USA (18%) is a front-runner in terms of funding blockchain initiatives. These "pacesetters"2 are optimistic that blockchain will deliver on its potential, with over 60% believing that blockchain is already transforming the way they collaborate with their partners.
The study also found that cost saving (89%), enhanced traceability (81%) and enhanced transparency (79%) are the top three drivers behind current investments in blockchain. Furthermore, blockchain enables information to be delivered securely, faster and more transparently. The technology can be applied to critical supply chain functions, from tracking production to monitoring food-chains and ensuring regulatory compliance. Enthused by the results they are seeing, the pacesetters identified in the study are set to grow their blockchain investment by 30% in the next three years.
Best Practices for Data Collection and Management in Clinical TrialsClinosolIndia
Data collection and management in clinical trials are crucial for ensuring the accuracy, integrity, and reliability of study findings. Here are some best practices for data collection and management in clinical trials:
Standardized Data Collection: Use standardized data collection tools, such as electronic case report forms (eCRFs), to ensure consistent and uniform data capture across study sites. Clearly define data fields, formats, and coding conventions to minimize variability and errors.
Training and Standard Operating Procedures (SOPs): Provide comprehensive training to study personnel on data collection procedures, including proper documentation, data entry, and quality control measures. Develop and implement SOPs that outline data collection, handling, and storage processes.
Source Data Verification (SDV): Perform regular source data verification to ensure the accuracy and completeness of data. Compare data entered in the eCRFs with original source documents (e.g., medical records, laboratory reports) to identify discrepancies and resolve any inconsistencies.
Data Quality Checks: Implement automated data quality checks to identify potential errors, outliers, and inconsistencies in the data. Range checks, logic checks, and consistency checks can help identify data entry errors or missing data points.
Data Security and Confidentiality: Implement robust data security measures to protect participant confidentiality and comply with data protection regulations. Use secure servers, encryption techniques, and access controls to prevent unauthorized access and ensure data privacy.
Data Monitoring and Audit Trails: Establish a data monitoring plan to regularly review and validate data for accuracy and completeness. Maintain an audit trail that tracks any changes made to the data, including the date, time, and reason for modifications.
Data Backup and Storage: Implement regular data backup procedures to prevent data loss. Store data securely and ensure appropriate backup storage to mitigate risks associated with data corruption or system failures.
Efficient Supervision Net: Polyp Segmentation using EfficientNet and Attentio...multimediaeval
Paper: http://ceur-ws.org/Vol-2882/paper72.pdf
Sabarinathan D and Suganya Ramamoorthy : Efficient Supervision Net: Polyp Segmentation using EfficientNet and Attention Unit. Proc. of MediaEval 2020, 14-15 December 2020, Online.
Colorectal cancer is the third most common cause of cancer worldwide. In the era of medical Industry, identifying colorectal cancer in its early stages has been a challenging problem. Inspired by these issues, the main objective of this paper is to develop a Multi supervision net algorithm for segmenting polys on a comprehensive dataset. The risk of colorectal cancer could be reduced by early diagnosis of poly during a colonoscopy. The disease and their symptoms are highly varying and always a need for a continuous update of knowledge for the doctors and medical analyst. The diseases fall into different categories and a small variation of symptoms may lead to higher rate of risk. We have taken Medico polyp challenge dataset, which consists of 1000 segmented polyp images from gastrointestinal track. We proposed an efficient Net B4 as a pre-trained architecture in multi-supervision net. The model is trained with multiple output layers. We present quantitative results on colorectal dataset to evaluate the performance and achieved good results in all the performance metrics. The experimental results proved that the proposed model is robust and provides a good level of accuracy in segmenting polyps on a comprehensive dataset for different metrics such as Dice coefficient, Recall, Precision and F2.
A partnership of funders invites applications for proposals to support networking of researchers from different disciplines relating to the topic of decision making under uncertainty. The theme of the call builds on a number of events held by the funding partners and Research Councils UK (RCUK).
There is a budget of up to £750,000 to support this activity, and we expect to fund a maximum of two networks, which will include support for feasibility projects, for two years.
Proposals will need to consider & seek to involve a wide breadth of relevant communities and build on current RCUK funded activities (see Annex I for examples).
The purpose of this call is to develop & build widespread linkages between disciplines related to decision making under uncertainty and grow a multidisciplinary community in this space. The network(s) will be expected to work with user organisations (policy-makers, industry, and/or civil society organisations) to analyse real-world systems and identify where multi-disciplinary research can develop new approaches to improve decision-making under uncertainty.
The COVID-19 coronavirus has impacted countries, communities and individuals in countless ways, from school closures to health-care insurance issues not to undermined loss of lives.
As governments scramble to address these problems, different solutions based on blockchain technologies have sprung up to help deal with the worldwide health crisis. Blockchain will surely not prevent the emergence of new viruses itself, but what it can do is create the first line of rapid protection through a network of connected devices whose primary goal is to remain alert about disease outbreaks.
Therefore, the use of blockchain-enabled platforms can help prevent these pandemics by enabling early detection of epidemics, fast-tracking drug trials, and impact management of outbreaks and treatment.
Similar to Supply Chain management with Demand Forecasting of Covid-19 Vaccine using Blockchain and Machine Learning (20)
Impact Prediction of Online Education during COVID-19 using Machine Learning_...Md. Mahfujur Rahman
Impact Prediction of Online Education during COVID-19 using Machine Learning: A Case Study. COVID-19 directly affected the students of Bangladesh
Long-term negative effects on students could have been devastating
A study was conducted to predict changes in patterns
The survey was done to collect data from private university students
Data were analyzed using machine learning approaches based on multiple features
Comparison between factors of impact was done through different models.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Supply Chain management with Demand Forecasting of Covid-19 Vaccine using Blockchain and Machine Learning
1. Paper ID: 419 - Supply Chain Management
with Demand Forecasting of Covid-19
Vaccine using Blockchain and Machine
Learning
Md. Mahfujur Rahman,
2. CONTENTS
❏ Introduction
❏ Research Objective
❏ Motivation
❏ Model Architecture
❏ Open Research Challenges
❏ Limitation and Future Research Direction
❏ Conclusion
3. Introduction
❖ Vaccination of the global population against COVID-19 is one of the
challenging tasks in supply chain management.
❖ It’s effectiveness depends on the availability of an operational and
transparent distribution chain that can be audited by all related
stakeholders
❖ In this paper, the necessity of Blockchain and Machine Learning in
supply-chain management with demand forecasting of the COVID-19
vaccine has been presented.
❖ The aim is to understand how the convergence of Blockchain technology
and ML monitor the prerequisite of vaccine distribution with demand
forecasting
4. Motivation
❖ To ensure the seamless COVID-19 vaccine
distribution with transparency, data integrity,
and end-to-end traceability for reducing risk,
assuring the safety, and also immutability
5. Research Objective
❖ The main objective of this paper is to propose a Blockchain and
Machine Learning based model in supply-chain management with
demand forecasting of the COVID-19 vaccine
❖ This work attempts to find solution on the following research
questions:
RQ1: How many vaccines to ship where and when?
RQ2: Which vaccine is to supply where and when?
RQ3: How to ensure seamless COVID-19 vaccines distribution
through Blockchain-based supply chain management?
❖ Lastly, we have discussed research challenges and also mentioning the
limitations with future directions.
7. Open Research Challenges
❖ Here we have analyzed the challenges that we may face to
implement the proposed model.
❖ Integration of Blockchain and ML in the vaccine supply chain is
still in its infancy.
❖ Different batches of the covid vaccine may be produced by
different contract manufacturers at different facilities, resulting in
variations among them, and there may be further issues around the
storage of individual lots of vials from within each batch.
❖ Most of the data is subjected to privacy policies and local
regulations such as vaccine development. Therefore, most of the data
is not easily accessible.
8. Open Research Challenges(Cont.)
❖ The majority of the software applications for the supply chain were
intended for use within a specific organization. For the proposed model,
we need to keep track of every activity as well as participants of the
network manufacturers, distributors, hospitals, pharmacies, etc.
❖ Moreover, some of these participants are competitors of each other that
are usually resistant to share data, or they may be incapable to share data
easily owing to security, regulatory, and compliance concerns.
❖ Building a unique platform to include all the participants/stakeholders
in vaccine distribution and demand forecasting is costly and time-
consuming.
9. ❖ In this paper, initial demand forecasting performance can be low
because of limited data in the Blockchain network.
❖ The proposed model only focuses on the most appropriate vaccine
forecasting in terms of geographical areas and storage facilities but
not the efficacy of the vaccines.
❖ But, while a significant number of people get vaccines then this
data can be used for efficacy prediction for the particular vaccine
❖ Proposed model needs to be implemented with a comparative
analysis of machine learning algorithms for demand forecasting.
Limitations and Future Research Directions
10. ❖ Therefore, future work is to focused on collecting COVID-19
vaccine distribution datasets and implement the proposed model for
the verification of the model's effectiveness.
Limitations and Future Research Directions
11. Conclusion
❖ In this paper, Blockchain-ML based model has been
proposed for the transparent tracing of COVID-19 vaccine
distribution with demand forecasting.
❖ Here, Blockchain technology is used to verify the vaccine
distribution process and chain of custody from
manufacturing to end-users.
❖ we have applied the Machine Learning model to forecast
the most appropriate COVID-19 vaccine based on the
available data.